Results 251 to 260 of about 54,430 (317)

Pulmonary vasodilator use in very preterm infants in United States children's hospitals. [PDF]

J Perinatol
Vega TF, Huber M, Jensen EA, Avitabile CM, Lorch SA, Gibbs KA, O'Byrne ML, Frank DB, Bamat NA.   +8 more
europepmc   +1 more source

GSNO as a Modulator of Vascular Tone in Human Saphenous Veins: Potential Implications for Graft Spasm. [PDF]

Life (Basel)
Kaleli Durman D, Dağtekin N, Civelek E, İyigün T, Teskin Ö, Uydeş Doğan BS.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Alkaloids as Vasodilator Agents: A Review

Current Pharmaceutical Design, 2023
Abstract: The pathophysiology of hypertension is often associated with endothelial dysfunction and the impairment of endothelium-dependent vasodilation mechanisms, as well as alterations in vascular smooth muscle (VSM) tone. Natural products, particularly alkaloids, have received increased attention in the search for new vasodilator agents.
Ayoub, Amssayef, Mohamed, Eddouks
openaire   +2 more sources

Vasodilating Agents

2015
This chapter discusses the salient features of arterial and venous dilating agents commonplace in the management of the post-cardiotomy surgical patient. A keen understanding of the underlying cellular mechanism, pharmacology, indication, safety profile, and controversies of clinical utility of vasodilating agents is imperative for routine use.
Shreyajit R. Kumar, Andrew Sosa, Ilan Margulis   +2 more
openaire   +1 more source

Intratracheal administration of pulmonary vasodilator agents

Pediatric Pulmonology, 1992
AbstractWe compared intravenous and intratracheal administration of histamine (0.4 and 1.6 kg/kg, respectively) and nitroglycerin (5.0 and 20.0 μg/kg, respectively) in seven hypoxemic 2 week old lambs, during right lung only perfusion, to see if intratracheal administration could limit their vasodilator action to the pulmonary vessels.
M A, D'Angeli, B W, Goetzman
openaire   +2 more sources

Positive Inotropic/Vasodilator Agents

Cardiology Clinics, 1989
Beta-adrenergic sympathomimetic agents such as dobutamine and dopamine, and phosphodiesterase inhibitors such as amrinone, milrinone, and enoxamone, exert a direct positive inotropic effect upon the myocardium by causing an increase in cyclic AMP levels. The phosphodiesterase inhibitors also exert a substantial direct vasodilator effect.
openaire   +2 more sources

Vasodilators as Antihypertensive Agents

1982
In this chapter, we will analyse the mode of action and therapeutic use of the ‘direct-acting smooth muscle relaxant antihypertensor drugs’. We will include in this class of drugs those antihypertensive compounds which are supposed to relax vascular smooth muscle without interfering with identified cell receptors (adrenergic, dopaminergic, angiotensin ...
M. Worcel, J. C. Gaignault
openaire   +1 more source

β-Blocking Agents with Vasodilating Action

Journal of Cardiovascular Pharmacology, 1992
beta-Adrenoceptor-blocking drugs in current use can be separated into two main groups: those nonselective and those selective for beta 1-receptors. Members of each group reduce cardiac output and lead to an increase in peripheral resistance with a concomitant reduction in blood flow.
openaire   +2 more sources

Beta-blocking agents with vasodilator activity

Journal of Hypertension, 1993
Use of non-selective beta-blockers: Non-selective beta-blockers reduce blood pressure by reducing cardiac output. They have a proven record of efficacy, alone or in combination with other drug classes, in the treatment of hypertension, ischemic heart disease and some tachyarrhythmias.
openaire   +2 more sources